Alzheimer’s ADHD

Showing 1 posts of 1 posts found.

AstraZeneca’s AZD3480 progresses in ADHD

July 11, 2009
Sales and Marketing ADHD, Alzheimer's, Alzheimer's ADHD, AstraZeneca

 AstraZeneca is to progress its AZD3480 (TC-1734) for attention deficit/hyperactivity disorder (ADHD) and has agreed to make a $10 million …

The Gateway to Local Adoption Series

Latest content